Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Liquid vs Lyophilized Pegaspargase in Pediatric ALL
NCT04954326Phase 2Completed
- Sponsor
- Servier
- Start
- May 2021
- Primary completion
- May 2022
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by Servier. Started May 2021; status: completed.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT04954326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04954326.